VANGUARD GROUP INC 13D and 13G filings for Amedisys, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Amedisys, Inc. AMED | VANGUARD GROUP INC | 3,218,592 9.860% | 90,176![]() (+2.88%) | Filing |
2023-02-09 11:07 am Sale | 2022-12-30 | 13G | Amedisys, Inc. AMED | VANGUARD GROUP INC | 3,128,416 9.630% | -30,361![]() (-0.96%) | Filing |
2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Amedisys, Inc. AMED | VANGUARD GROUP INC | 3,158,777 9.690% | 131,642![]() (+4.35%) | Filing |
2021-02-10 10:30 am Sale | 2020-12-31 | 13G | Amedisys, Inc. AMED | VANGUARD GROUP INC | 3,027,135 9.230% | -113,593![]() (-3.62%) | Filing |